Herbalife initiated with a Buy at Maxim

Group 1 - Maxim analyst Anthony Vendetti initiated coverage of Herbalife (HLF) with a Buy rating and a price target of $20 [1] - A turnaround is underway for Herbalife, enabling the company to solidify its status as a leading provider of health and wellness products [1] - Maxim believes that U.S. regulatory concerns have been resolved, leading to a more sustainable business model through changes in distributor compensation alignment with sales to end users [1]